Editorial board

Editor-in-Chief

Janusz Jankowski ─   Institute for Clinical Trials, University College London, UK

Editorial Board 

Raja A Ali, MD ─ Hospital Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
Zhikai Chi, MD, PhD ─ The University of Texas Southwestern Medical Center, Dallas, TX, USA
Oliver Fisher, MD, PhD, FMH, FRACS ─ St. George Hospital, Kogarah, Australia
Umar Hayat, MD ─ University Hospitals, Cleveland, OH, USA
Sima Jabbari, Pharm.D. ─ Dubai Medical University, Dubai, United Arab Emirates
Robin Jones, MRCP, MD ─ The Royal Marsden Hospital NHS Trust, London, UK; Institute of Cancer Research, London, UK
Michal F. Kaminski, MD, PhD ─ National Research Institute of Oncology, Warsaw, Poland; Medical Center for Postgraduate Education, Warsaw, Poland
Shifan Khanday, MBBS, MD, DFM, MBA, PhD, MHPE, Msc ─  Dubai College for Girls, Dubai, United Arab Emirates
David MacDonald, DDS, FDSRCPS, DDRRCR, FRCD ─  The University of British Columbia, Vancouver, BC Canada
Amrita Sen Mukherjee, MSc ─ Royal College of Surgeons, Dublin, Ireland
Hans Prenen, MD, PhD ─ University Hospital Antwerp, Antwerp, Belgium
Carlo Pulitano, MD, PhD, FRACS ─ The University of Sydney, Camperdown, Australia
Alessandro Rizzo, MD ─ Ospedale Oncologico "Giovanni Paolo II" di Bari, Bari, Italy
Elizabeth Smyth, MD ─ Cambridge University Hospitals NHS Foundation Trust, Hill's Road, Cambridge, UK